Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
279.31
+5.25 (1.92%)
May 2, 2024, 4:00 PM EDT - Market closed

Bio-Rad Laboratories Revenue

In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, a decrease of -4.67%. Revenue in the quarter ending December 31, 2023 was $681.18M, a -6.72% decrease year-over-year.

Revenue (ttm)
$2.67B
Revenue Growth
-4.67%
P/S Ratio
3.00
Revenue / Employee
$332,660
Employees
8,030
Market Cap
8.01B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.67B-130.99M-4.67%
Dec 31, 20222.80B-120.30M-4.12%
Dec 31, 20212.92B376.92M14.81%
Dec 31, 20202.55B233.97M10.12%
Dec 31, 20192.31B22.24M0.97%
Dec 31, 20182.29B129.26M5.98%
Dec 31, 20172.16B91.98M4.45%
Dec 31, 20162.07B48.73M2.41%
Dec 31, 20152.02B-155.60M-7.15%
Dec 31, 20142.18B42.35M1.99%
Dec 31, 20132.13B63.46M3.07%
Dec 31, 20122.07B-4.29M-0.21%
Dec 31, 20112.07B146.41M7.60%
Dec 31, 20101.93B142.87M8.01%
Dec 31, 20091.78B19.88M1.13%
Dec 31, 20081.76B303.31M20.76%
Dec 31, 20071.46B187.12M14.69%
Dec 31, 20061.27B92.95M7.87%
Dec 31, 20051.18B90.97M8.35%
Dec 31, 20041.09B110.38M11.27%
Dec 31, 2003979.63M114.63M13.25%
Dec 31, 2002865.01M47.50M5.81%
Dec 31, 2001817.51M91.63M12.62%
Dec 31, 2000725.88M170.49M30.70%
Dec 31, 1999555.40M107.54M24.01%
Dec 31, 1998447.86M20.95M4.91%
Dec 31, 1997426.91M8.13M1.94%
Dec 31, 1996418.79M22.17M5.59%
Dec 31, 1995396.62M41.32M11.63%
Dec 31, 1994355.30M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Encompass Health 4.80B
Masimo 2.05B
Exelixis 1.85B
Penumbra 1.06B
Inspire Medical Systems 624.80M
Intra-Cellular Therapies 464.37M
Ascendis Pharma 296.35M
Legend Biotech 285.14M
Revenue Rankings